RESUMEN
INTRODUCTION: Allergic rhinoconjunctivitis and asthma are the most common IgE-mediated diseases worldwide. Allergen-specific immunotherapy (AIT) is currently the only modifying treatment for these IgE-mediated diseases in both children and adults. Subcutaneous immunotherapy is widely used, but in patients over 65 years old, there may be an increased risk of adverse reactions and a worse response to treatment. Oral immunotherapy (OIT) has been proven to be effective and safe, but currently, in most countries, it has been licensed only for patients up to 65 years old based on its technical datasheet. So far, no studies on the efficacy and safety of this type of immunotherapy in patients older than 65 years old have been published. CASE PRESENTATION: We present four patients older than 65 years old with a diagnosis of moderate seasonal rhinoconjunctivitis and moderate-persistent seasonal pollen-induced asthma. Off-label use of oral immunotherapy (OIT) for grass pollen was prescribed due to the severity of their rhinoconjunctivitis symptoms and the worsening of asthma symptoms during the spring. Improvement in the rhinoconjunctivitis and asthma symptoms was reported by all patients since the first spring season and was maintained during the following two years of follow-up. There were no systemic reactions, and only two patients initially had self-limiting oral pruritus. CONCLUSION: Oral immunotherapy for pollens appears to be a convenient, effective, and safe option in older patients (>65 years) with comorbidities after a three-year treatment. This is, to the best of our knowledge, the first report on the off-label use of OIT in patients over 65 years old with symptoms of allergic rhinoconjunctivitis and asthma.
Asunto(s)
Asma , Conjuntivitis Alérgica , Rinitis Alérgica Estacional , Adulto , Niño , Humanos , Anciano , Conjuntivitis Alérgica/terapia , Conjuntivitis Alérgica/etiología , Uso Fuera de lo Indicado , Poaceae/efectos adversos , Comprimidos , Polen , Rinitis Alérgica Estacional/terapia , Rinitis Alérgica Estacional/etiología , Desensibilización Inmunológica/efectos adversos , Asma/terapia , Inmunoglobulina E , Resultado del TratamientoRESUMEN
BACKGROUND: Cassia angustifolia, or senna, is a plant belonging to the Fabaceae family, widely used as a laxative and as a colouring agent in hair dyes. Senna is rarely reported as an occupational allergic sensitizer in the current literature. AIMS: To describe the case and diagnostic approach of a suspected occupational senna allergy. CASE REPORT: A male phytopharmaceutical warehouse worker reported bronchial, conjunctival and nasal symptoms immediately upon exposure to senna. We were able to document in vitro sensitization, finding IgE-binding proteins in senna, and in vivo sensitization through positive skin tests and conjunctival provocation test. CONCLUSION: Our study confirms that senna may cause occupational rhinoconjunctivitis symptoms with an IgE-dependent mechanism and is the first to confirm it through specific conjunctival provocation test.
Asunto(s)
Exposición Profesional/efectos adversos , Extracto de Senna/efectos adversos , Pruebas de Provocación Bronquial/métodos , Conjuntivitis Alérgica/etiología , Humanos , Hipersensibilidad/complicaciones , Inmunoglobulina E/análisis , Inmunoglobulina E/sangre , Masculino , Persona de Mediana Edad , Senna/efectos adversosRESUMEN
PURPOSE OF REVIEW: The purpose of the article is to provide a historical overview of literature regarding pollen sensitization and ocular allergy with an emphasis on developments that have occurred over the past 5 years. RECENT FINDINGS: Currently, pollen studies have examined the molecular and cellular pathways involved in initiating allergic conjunctivitis to find targets for therapeutics. Studies have also documented the threshold, linear increase and plateau point in the relationship between pollen levels and allergic conjunctivitis symptoms. SUMMARY: Traditionally, intact pollen grains are counted as a means of correlating patient symptoms to allergen exposure. However, establishing a dose-response relationship between pollen grain exposure and allergic conjunctivitis has proven to be difficult. It has been observed that ocular allergies induce a two-fold response including early-phase and late-phase IgE-mediated reactions. Sensitization itself is a combination of pollen exposure over time in genetically predisposed individual. However, symptoms appear to reach an asymptotic point at which clinical severity plateaus. More studies are needed to clearly define differences in pollen sensitization by plant species.
Asunto(s)
Alérgenos/inmunología , Conjuntivitis Alérgica/inmunología , Polen/inmunología , Rinitis Alérgica Estacional/inmunología , Estaciones del Año , Alérgenos/efectos adversos , Conjuntivitis Alérgica/etiología , Humanos , Polen/efectos adversos , Rinitis Alérgica Estacional/etiología , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND: Timothy grass pollen allergen extract tablets (Grastek) are standardized sublingual immunotherapy tablets (SLIT-T) approved for the treatment of grass pollen-induced allergic rhinitis (AR) and conjunctivitis. Many grass allergic patients are also cosensitized to birch pollen. Whether Timothy grass SLIT-T can confer symptomatic benefits for birch pollen-induced AR symptoms is unknown. OBJECTIVE: To evaluate the treatment effect of Timothy grass SLIT-T for birch pollen-induced AR in participants sensitized to both grass and birch pollen using an environmental exposure unit (EEU). METHODS: This study was a phase 4, randomized, double-blind, placebo-controlled, parallel-group study that enrolled participants aged 18 to 65 years allergic to both timothy grass and birch pollen. After a baseline EEU birch pollen challenge, in which a minimum total nasal symptom score (TNSS) of 6 of 12 was required for enrollment, participants were randomized to receive Timothy grass SLIT-T or placebo taken once daily for 4 months. No confirmatory grass pollen challenge was performed. The primary end point was the change in TNSS averaged from assessments from hours 2 to 5 during the posttreatment birch pollen challenge compared with baseline. The secondary and exploratory end points included temporally identical changes in total ocular symptom score (TOSS), total rhinoconjunctivitis symptom score (TRSS), and individual symptom scores. RESULTS: The difference in TNSS reduction after 4 months of therapy between the Timothy grass SLIT-T and placebo group was not significant (P = .83). Reductions in TOSS (P = .19) and TRSS (P = .67) were also comparable between groups. Findings between groups for individual symptom scores were similar (all P > .40), except for watery eyes, in which symptom reduction was slightly better in the placebo arm (P = .01). Timothy grass SLIT-T was well tolerated, and no serious adverse effects occurred. CONCLUSION: A bystander effect of grass SLIT-T on birch pollen-induced AR symptoms was not detected. Symptomatic benefits of grass SLIT-T are likely allergen specific. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02394600.
Asunto(s)
Alérgenos/inmunología , Betula/inmunología , Conjuntivitis Alérgica/terapia , Exposición a Riesgos Ambientales/efectos adversos , Phleum/inmunología , Rinitis Alérgica Estacional/terapia , Inmunoterapia Sublingual/métodos , Administración Sublingual , Adolescente , Adulto , Anciano , Alérgenos/administración & dosificación , Alérgenos/química , Betula/química , Biomarcadores , Conjuntivitis Alérgica/etiología , Conjuntivitis Alérgica/inmunología , Conjuntivitis Alérgica/fisiopatología , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Phleum/química , Polen/química , Polen/inmunología , Proyectos de Investigación , Rinitis Alérgica Estacional/etiología , Rinitis Alérgica Estacional/inmunología , Rinitis Alérgica Estacional/fisiopatología , ComprimidosRESUMEN
Innate immunity has been extended to respond environmental pathogen other than microbial components. Here we explore a novel pollen/TLR4 innate immunity in allergic inflammation. In experimental allergic conjunctivitis induced by short ragweed (SRW) pollen, typical allergic signs, stimulated IL-33/ST2 signaling and overproduced Th2 cytokine were observed in ocular surface, cervical lymph nodes and isolated CD4+ T cells of BALB/c mice. These clinical, cellular and molecular changes were significantly reduced/eliminated in TLR4 deficient (Tlr4-d) or MyD88 knockout (MyD88-/-) mice. Aqueous SRW extract (SRWe) directly stimulated IL-33 mRNA and protein expression by corneal epithelium and conjunctiva in wild type, but not in Tlr4-d or MyD88-/- mice with topical challenge. Furthermore, SRWe-stimulated IL-33 production was blocked by TLR4 antibody and NF-kB inhibitor in mouse and human corneal epithelial cells. These findings for the first time uncovered a novel mechanism by which SRW pollen initiates TLR4-dependent IL-33/ST2 signaling that triggers Th2-dominant allergic inflammation.
Asunto(s)
Antígenos de Plantas/inmunología , Inmunidad Innata/efectos de los fármacos , Proteína 1 Similar al Receptor de Interleucina-1/metabolismo , Interleucina-33/metabolismo , Extractos Vegetales/inmunología , Células Th2/inmunología , Receptor Toll-Like 4/metabolismo , Adulto , Animales , Antígenos de Plantas/metabolismo , Células Cultivadas , Conjuntiva/efectos de los fármacos , Conjuntiva/metabolismo , Conjuntiva/patología , Conjuntivitis Alérgica/etiología , Conjuntivitis Alérgica/inmunología , Conjuntivitis Alérgica/metabolismo , Córnea/efectos de los fármacos , Córnea/metabolismo , Córnea/patología , Citocinas/análisis , Citocinas/genética , Citocinas/metabolismo , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Femenino , Humanos , Proteína 1 Similar al Receptor de Interleucina-1/genética , Interleucina-33/genética , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Persona de Mediana Edad , Factor 88 de Diferenciación Mieloide/deficiencia , Factor 88 de Diferenciación Mieloide/genética , FN-kappa B/antagonistas & inhibidores , FN-kappa B/metabolismo , Extractos Vegetales/metabolismo , Extractos Vegetales/toxicidad , Transducción de Señal , Células Th2/citología , Receptor Toll-Like 4/deficiencia , Receptor Toll-Like 4/genéticaRESUMEN
We present a case report of occupational allergic rhinoconjunctivitis after exposure to dust from ginger-containing herbal medicine. The likelihood of an aetiological connection between exposure and the patient's symptoms was supported by a temporal association, positive specific IgE, positive histamine release test, positive prick test, and positive acoustic rhinometry test. Occupational allergy to ginger has rarely been reported. The cases described - including the one we present - suggest that work-related IgE-mediated allergy is associated with exposure to dry aerosols/dust.
Asunto(s)
Conjuntivitis Alérgica/etiología , Rinitis Alérgica/etiología , Zingiber officinale/inmunología , Conjuntivitis Alérgica/diagnóstico , Femenino , Humanos , Persona de Mediana Edad , Exposición Profesional/efectos adversos , Rinitis Alérgica/diagnósticoAsunto(s)
Alérgenos/uso terapéutico , Conjuntivitis Alérgica/terapia , Desensibilización Inmunológica , Poaceae/inmunología , Rinitis Alérgica Estacional/terapia , Administración Sublingual , Adulto , Alérgenos/administración & dosificación , Alérgenos/inmunología , Ambrosia/efectos adversos , Ambrosia/inmunología , Anafilaxia/etiología , Antígenos Dermatofagoides/administración & dosificación , Antígenos Dermatofagoides/inmunología , Antígenos Dermatofagoides/uso terapéutico , Conjuntivitis Alérgica/etiología , Conjuntivitis Alérgica/inmunología , Contraindicaciones , Desensibilización Inmunológica/efectos adversos , Desensibilización Inmunológica/economía , Método Doble Ciego , Edema/etiología , Humanos , Masculino , Estudios Multicéntricos como Asunto , Absorción por la Mucosa Oral , Aceptación de la Atención de Salud , Poaceae/efectos adversos , Polen/efectos adversos , Polen/inmunología , Prurito/etiología , Ensayos Clínicos Controlados Aleatorios como Asunto , Rinitis Alérgica Estacional/etiología , Rinitis Alérgica Estacional/inmunología , Comprimidos , Células Th2/inmunologíaRESUMEN
BACKGROUND: Diet might influence the risk of allergic diseases. Evidence from developing countries with high prevalence of childhood asthma is scant. METHODS: Information on wheeze, rhinitis, and eczema was collected from 3209 children aged 6-7 years in 2005, who were taking part in the International Study on Asthma and Allergy in Children (ISAAC) in Colombia. Intake frequency of twelve food groups was assessed. Associations between each food group and current wheeze, rhino-conjunctivitis, and eczema were investigated with multiple logistic regressions, adjusting for potential confounders. Simes' procedure was used to test for multiple comparisons. RESULTS: 14.9% of children reported wheeze in the last 12 months, 16% rhino-conjunctivitis, and 22% eczema. Eczema was negatively associated with consumption of fresh fruits and pulses three or more times per week (adjusted Odds ratio (aOR): 0.64; 95% Confidence Interval (CI): 0.49 to 0.83; p value = 0.004; and aOR: 0.62, 95% CI: 0.47 to 0.80; p value < 0.001, respectively). Current wheeze was negatively associated with intake of potatoes (aOR: 0.44, 95% CI: 0.31 to 0.62, p value = 0.005), whilst this outcome was positively associated with consumption of fast food (aOR: 1.76, 95% CI: 1.32 to 2.35, p value = 0.001). These associations remained statistically significant after controlling for multiple comparisons. CONCLUSIONS: A traditional diet might have a protective effect against eczema and wheeze in Colombian children, whilst intake of fast foods increases this risk.
Asunto(s)
Conjuntivitis Alérgica/etiología , Dermatitis Atópica/etiología , Dieta , Comida Rápida/efectos adversos , Ruidos Respiratorios/etiología , Rinitis Alérgica/etiología , Niño , Colombia/epidemiología , Conjuntivitis Alérgica/epidemiología , Dermatitis Atópica/epidemiología , Dieta/efectos adversos , Encuestas sobre Dietas , Femenino , Frutas , Humanos , Modelos Logísticos , Masculino , Oportunidad Relativa , Prevalencia , Rinitis Alérgica/epidemiología , Factores de Riesgo , Conducta de Reducción del Riesgo , Solanum tuberosumRESUMEN
INTRODUCTION: The objective of this study was to compare the efficacy and safety of olopatadine versus epinastine in healthy Japanese adults with a history of allergic conjunctivitis to Japanese cedar pollen. METHODS: This Phase IV double-blind randomized controlled clinical trial comprised three clinical visits over 30 days. Screening tests were performed to identify subjects with a history of allergic conjunctivitis to Japanese cedar pollen in terms of skin sensitivity and positive bilateral reactions to a conjunctival allergen challenge (CAC) with Japanese cedar pollen at Visit 1, and confirmation by a positive bilateral CAC reaction at Visit 2. At Visit 3, the subjects were randomized to receive one drop of olopatadine HCl ophthalmic solution 0.1% (olopatadine) in the left or right eye (1:1 ratio). All subjects received one drop of epinastine HCl ophthalmic solution 0.05% (epinastine) in the contralateral eye as an active control. Five min later, the subjects underwent bilateral CAC tests with one drop of the allergen solution at the concentration that elicited positive reactions at Visits 1 and 2. Efficacy outcomes included the severity of ocular itching at 5, 7, and 15 min and the severity of conjunctival hyperemia at 7, 15, and 20 min after the CAC test, as graded by the investigator by biomicroscopy. RESULTS: Fifty people participated in this study (25 per group). Olopatadine significantly reduced ocular itching at 7 and 15 min (both p<0.05) and conjunctival hyperemia at 7 and 20 min (p=0.0010 and p<0.05, respectively) after allergen exposure compared with epinastine. There were no adverse events for either treatment. CONCLUSION: The results of this single-dose study suggest that olopatadine is superior to epinastine in terms of suppressing ocular itching and hyperemia induced by Japanese cedar pollen during CAC tests. Further studies are needed to confirm these findings in real-life settings.
Asunto(s)
Alérgenos , Conjuntivitis Alérgica , Cryptomeria , Dibenzazepinas/administración & dosificación , Imidazoles/administración & dosificación , Clorhidrato de Olopatadina/administración & dosificación , Polen , Adulto , Antialérgicos/administración & dosificación , Antialérgicos/efectos adversos , Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/tratamiento farmacológico , Conjuntivitis Alérgica/etiología , Dibenzazepinas/efectos adversos , Método Doble Ciego , Femenino , Humanos , Imidazoles/efectos adversos , Japón , Masculino , Clorhidrato de Olopatadina/efectos adversos , Soluciones Oftálmicas , Índice de Severidad de la Enfermedad , Pruebas Cutáneas/métodos , Resultado del TratamientoAsunto(s)
Contaminantes Atmosféricos/efectos adversos , Conjuntivitis Alérgica/etiología , Animales , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Polvo , Humanos , Ratones , Material Particulado/efectos adversos , Polen/efectos adversos , Esmog/efectos adversos , Contaminantes del Suelo/efectos adversos , Emisiones de VehículosRESUMEN
The prevalence of seasonal allergic rhinitis can be established through surveys performed in a sample of the general population. These surveys are based on a questionnaire, which could lead to an overestimate of prevalence rates, and on measurements of specific IgE, which need to be interpreted in the light of the responses to the questionnaire. Such surveys are few in France and need to be updated. Risk factors for seasonal allergic rhinitis are genetic, epigenetic and environmental. Relationships between exposure to pollen and health can be documented through ecological and panel surveys. Panel surveys may give information on threshold levels and dose-response relationships. In addition to pollen exposure, global warming and air pollutants act as cofactors. Monitoring of both pollen exposure and its health effects should be encouraged and strengthened.
Asunto(s)
Polen/efectos adversos , Rinitis Alérgica Estacional/epidemiología , Edad de Inicio , Contaminación del Aire/efectos adversos , Estudios de Cohortes , Conjuntivitis Alérgica/epidemiología , Conjuntivitis Alérgica/etiología , Relación Dosis-Respuesta Inmunológica , Exposición a Riesgos Ambientales , Epigénesis Genética , Europa (Continente)/epidemiología , Francia/epidemiología , Predisposición Genética a la Enfermedad , Encuestas Epidemiológicas , Humanos , Hipersensibilidad Inmediata/genética , Inmunoglobulina E/inmunología , Conceptos Meteorológicos , Estudios Multicéntricos como Asunto , Polen/inmunología , Prevalencia , Rinitis Alérgica Estacional/etiología , Factores de Riesgo , Encuestas y Cuestionarios , Contaminación por Humo de Tabaco/efectos adversosRESUMEN
Pollen is the most common aeroallergen to cause seasonal conjunctivitis. The result of allergen exposure is a strong Th2-mediated response along with conjunctival mast cell degranulation and eosinophilic infiltration. Oleanolic acid (OA) is natural a triterpene that displays strong anti-inflammatory and immunomodulatory properties being an active anti-allergic molecule on hypersensitivity reaction models. However, its effect on inflammatory ocular disorders including conjunctivitis, has not yet been addressed. Hence, using a Ragweed pollen (RWP)-specific allergic conjunctivitis (EAC) mouse model we study here whether OA could modify responses associated to allergic processes. We found that OA treatment restricted mast cell degranulation and infiltration of eosinophils in conjunctival tissue and decreased allergen-specific Igs levels in EAC mice. Th2-type cytokines, secreted phospholipase A2 type-IIA (sPLA2-IIA), and chemokines levels were also significantly diminished in the conjunctiva and serum of OA-treated EAC mice. Moreover, OA treatment also suppressed RWP-specific T-cell proliferation. In vitro studies, on relevant cells of the allergic process, revealed that OA reduced the proliferative and migratory response, as well as the synthesis of proinflammatory mediators on EoL-1 eosinophils and RBL-2H3 mast cells exposed to allergic and/or crucial inflammatory stimuli such as RWP, sPLA2-IIA or eotaxin. Taken together, these findings demonstrate the beneficial activity of OA in ocular allergic processes and may provide a new intervention strategy and potential therapy for allergic diseases.
Asunto(s)
Antialérgicos/farmacología , Conjuntiva/efectos de los fármacos , Conjuntivitis Alérgica/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Modelos Animales , Ácido Oleanólico/farmacología , Alérgenos/toxicidad , Animales , Proliferación Celular/efectos de los fármacos , Conjuntiva/citología , Conjuntiva/inmunología , Conjuntivitis Alérgica/etiología , Conjuntivitis Alérgica/inmunología , Citocinas/metabolismo , Eosinófilos/citología , Eosinófilos/efectos de los fármacos , Eosinófilos/inmunología , Femenino , Citometría de Flujo , Inmunización , Inmunoglobulina E/metabolismo , Inflamación/etiología , Inflamación/inmunología , Mastocitos/citología , Mastocitos/efectos de los fármacos , Mastocitos/inmunología , Ratones , Ratones Endogámicos BALB C , Polen/toxicidadRESUMEN
OBJECTIVE: To investigate whether artificial tears and cold compress alone or in combination provide a treatment benefit and whether they were as effective as or could enhance topical antiallergic medication. DESIGN: Randomized, masked clinical trial. PARTICIPANTS: Eighteen subjects (mean age, 29.5±11.0 years) allergic to grass pollen. INTERVENTION: Controlled exposure to grass pollen using an environmental chamber to stimulate an ocular allergic reaction followed by application of artificial tears (ATs), 5 minutes of cold compress (CC), ATs combined with CC, or no treatment applied at each separate visit in random order. A subset of 11 subjects also had epinastine hydrochloride (EH) applied alone and combined with CC in random order or instillation of a volume-matched saline control. MAIN OUTCOME MEASURES: Bulbar conjunctival hyperemia, ocular surface temperature, and ocular symptoms repeated before and every 10 minutes after treatment for 1 hour. RESULTS: Bulbar conjunctival hyperemia and ocular symptoms decreased and temperature recovered to baseline faster with nonpharmaceutical treatments compared with no treatment (P <0.05). Artificial tears combined with CC reduced hyperemia more than other treatments (P <0.05). The treatment effect of EH was enhanced by combining it with a CC (P <0.001). Cold compress combined with ATs or EH lowered the antigen-raised ocular surface temperature to less than the pre-exposure baseline. Artificial tear instillation alone or CC combined with ATs or EH significantly reduced the temperature (P <0.05). Cold compress combined with ATs or EH had a similar cooling effect (P >0.05). At all measurement intervals, symptoms were reduced for both EH and EH combined with CC than CC or ATs alone or in combination (P <0.014). CONCLUSIONS: After controlled exposure to grass pollen, CC and AT treatment showed a therapeutic effect on the signs and symptoms of allergic conjunctivitis. A CC enhanced the use of EH alone and was the only treatment to reduce symptoms to baseline within 1 hour of antigenic challenge. Signs of allergic conjunctivitis generally were reduced most by a combination of a CC in combination with ATs or EH.
Asunto(s)
Conjuntivitis Alérgica/terapia , Crioterapia , Soluciones Oftálmicas/administración & dosificación , Estaciones del Año , Enfermedad Aguda , Adulto , Anciano , Alérgenos/efectos adversos , Terapia Combinada , Conjuntiva/irrigación sanguínea , Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/etiología , Dibenzazepinas/administración & dosificación , Método Doble Ciego , Femenino , Antagonistas de los Receptores Histamínicos H1/administración & dosificación , Humanos , Hiperemia/inducido químicamente , Hiperemia/tratamiento farmacológico , Imidazoles/administración & dosificación , Masculino , Persona de Mediana Edad , Polen/efectos adversos , Pruebas Cutáneas , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Although allergen avoidance can lead to significant improvements in symptoms of allergic rhinitis, there are very few studies in this area. Sunglasses could be effective for protection of eyes from pollen as a cheap, comfortable, and simple avoidance option for allergens. The aim of this study is to determine if wearing sunglasses can decrease ocular symptoms. METHODS: Ocular symptomatic patients (39 total) who had a confirmed history of seasonal rhinitis by skin prick tests and negative skin prick tests for perennial allergens were included in the study. The duration of the study was 4 weeks with 3 required visits. At the onset of the 1-week run-in period, patients were randomized and divided into 2 groups. Group I (n = 18) received topical aqueous nasal budesonide regularly and loratadine once daily as a rescue medication. Group II (n = 21) wore sunglasses during daytime as an addition to this medication. Subjective data included a daily diary recording nasal and ocular symptom scores and antihistamine need during the study period. RESULTS: Sunglasses significantly reduced ocular symptoms (p = 0.002) and use of antihistamines (p = 0.009). CONCLUSION: Sunglasses are an inexpensive and simple treatment for patients with allergic conjunctivitis.
Asunto(s)
Conjuntivitis Alérgica , Dispositivos de Protección de los Ojos , Polen/efectos adversos , Rinitis Alérgica Estacional/complicaciones , Adulto , Antiinflamatorios/uso terapéutico , Budesonida/uso terapéutico , Conjuntivitis Alérgica/etiología , Conjuntivitis Alérgica/prevención & control , Femenino , Antagonistas de los Receptores Histamínicos H1 no Sedantes/uso terapéutico , Humanos , Loratadina/uso terapéutico , Masculino , Rinitis Alérgica Estacional/tratamiento farmacológico , Resultado del Tratamiento , Adulto JovenAsunto(s)
Asma/epidemiología , Clima , Conjuntivitis Alérgica/epidemiología , Conjuntivitis Alérgica/etiología , Polen/efectos adversos , Rinitis Alérgica Estacional/epidemiología , Rinitis Alérgica Estacional/etiología , Asma/etiología , Humanos , Estaciones del Año , Temperatura , Turquía/epidemiología , VientoRESUMEN
Pharmacologic inhibitors of IκB kinase (IKK), especially IKK-ß, have been developed to treat inflammatory diseases. However, their interactions with components of the NF-κB pathways are not fully known in allergic diseases. To examine whether IKK is involved in immediate hypersensitivity reactions and to determine whether counterregulatory mechanisms in the NF-κB activation system were active, we examined the role played by IKK components on mast cell degranulation using a murine ocular immediate hypersensitivity reaction model. Pharmacologic inhibition of IKK in mice caused paradoxical aggravation of the mast cell-mediated immediate hypersensitivity reaction and up-regulation in the expression of inflammatory cytokines. Downstream analyses showed that B-cell deficiency or treatment by IL-1 receptor antagonist corrected the aberrant activation of tissue-resident mast cells, which would indicate contribution by activated B cells. Analyses of co-cultures of tissue-resident mast cells showed the contribution of activated B cells to activation of mast cells and secretion of inflammatory cytokines. Aberrant activation of the NF-κB promoter in isolated B cells was induced exclusively by IKK-ß inhibition and was negated by ablating IKK-α. Aggravated mast cell degranulation by pharmacologic IKK inhibition in the murine immediate hypersensitivity reaction was corrected by B-cell-targeted inhibition of IKK-α. Thus, IKK-ß limits B-cell-mediated mast cell activation and inflammatory cytokine induction in immediate hypersensitivity by counterbalancing the activity of IKK-α.
Asunto(s)
Linfocitos B/enzimología , Conjuntivitis Alérgica/enzimología , Quinasa I-kappa B/antagonistas & inhibidores , Mastocitos/enzimología , Animales , Antígenos de Plantas/administración & dosificación , Antígenos de Plantas/efectos adversos , Linfocitos B/efectos de los fármacos , Biomarcadores/metabolismo , Western Blotting , Conjuntivitis Alérgica/etiología , Conjuntivitis Alérgica/inmunología , Citocinas/metabolismo , Ensayo de Inmunoadsorción Enzimática , Quinasa I-kappa B/metabolismo , Mastocitos/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , FN-kappa B/metabolismo , Extractos Vegetales/administración & dosificación , Extractos Vegetales/efectos adversos , Inhibidores de Proteínas Quinasas/administración & dosificación , Inhibidores de Proteínas Quinasas/farmacología , Reacción en Cadena en Tiempo Real de la Polimerasa , beta-N-Acetilhexosaminidasas/metabolismoRESUMEN
BACKGROUND: Patients allergic to pollen have been known to become more symptomatic during pollen season compared with the nonpollen season. However, there are few studies regarding whether higher exposure to pollen might increase the prevalence of allergic diseases. METHODS: An ecological analysis was conducted to evaluate whether pollen exposure is associated with the prevalence of allergic diseases in schoolchildren. Pollen count data of Japanese cedar (Cryptomeria japonica) and Japanese cypress (Chamaecyparis obtusa), which are the major pollen allergens in Japan, were obtained from each prefecture. The prevalence of allergic diseases in schoolchildren in each prefecture was based on a nationwide cross-sectional survey using the International Study of Asthma and Allergies in Childhood questionnaire. RESULTS: After omitting three prefectures where pollen data were not available, data of 44 prefectures were analysed. The prevalence of allergic rhinoconjunctivitis in children aged 6-7 years was positively associated with both cedar and cypress pollen counts (P = 0.01, both), whereas the prevalence of allergic rhinoconjunctivitis in children aged 13-14 years was positively associated with only cypress pollen counts (P = 0.003). Furthermore, the prevalence of asthma was positively associated with cedar pollen counts in 6- to 7-year-old children (P = 0.003) but not cypress pollen counts in either age group. CONCLUSIONS: There are ecological associations between pollen counts and the prevalence of allergic diseases in Japanese schoolchildren. Further studies are needed to determine whether the difference between the effects of cedar and cypress pollens is attributable to pollen counts or allergenicity.
Asunto(s)
Alérgenos/efectos adversos , Chamaecyparis/efectos adversos , Cryptomeria/efectos adversos , Exposición a Riesgos Ambientales/estadística & datos numéricos , Hipersensibilidad Inmediata/etiología , Polen/efectos adversos , Adolescente , Alérgenos/análisis , Asma/epidemiología , Asma/etiología , Niño , Conjuntivitis Alérgica/epidemiología , Conjuntivitis Alérgica/etiología , Estudios Transversales , Exposición a Riesgos Ambientales/efectos adversos , Exposición a Riesgos Ambientales/análisis , Femenino , Encuestas Epidemiológicas , Humanos , Hipersensibilidad Inmediata/epidemiología , Japón/epidemiología , Masculino , Análisis Multivariante , Prevalencia , Análisis de Regresión , Rinitis Alérgica Estacional/epidemiología , Rinitis Alérgica Estacional/etiología , Encuestas y CuestionariosRESUMEN
Grass pollen-induced allergic rhinoconjunctivitis is a common disease, comprising more than just the classic symptoms of nasal obstruction, sneezing, rhinorrhea and itchy, watery eyes. Sufferers deal with severe impairments in daily life. Allergic rhinoconjunctivitis is also considered an important risk factor in the development of asthma. Allergen avoidance, medication for symptomatic treatment and allergen-specific immunotherapy are cornerstones in therapeutic management, but immunotherapy is the only available treatment that is able to affect the natural course of allergy. In recent decades, clinical trials have investigated the efficacy and safety of subcutaneous immunotherapy. To date, efforts have been made to develop more convenient routes of administration. Substantial improvement may be achieved through the application of sublingual tablets. This article discusses the development process of immunotherapy and the clinical background of the Oralair(®) (Stallergènes, Hauts-de-Seine, France) five-grass pollen tablet. Furthermore, it outlines this tablet's efficacy and safety properties.
Asunto(s)
Desensibilización Inmunológica/métodos , Poaceae/inmunología , Polen/inmunología , Comprimidos/administración & dosificación , Administración Sublingual , Adulto , Niño , Preescolar , Conjuntivitis Alérgica/etiología , Conjuntivitis Alérgica/inmunología , Conjuntivitis Alérgica/terapia , Desensibilización Inmunológica/efectos adversos , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto , Rinitis Alérgica Estacional/etiología , Rinitis Alérgica Estacional/inmunología , Rinitis Alérgica Estacional/terapia , Comprimidos/uso terapéutico , Resultado del TratamientoRESUMEN
BACKGROUND: The level of concordance between allergic symptoms induced on exposure to pollen in a pollen challenge chamber (PCC) versus the natural season is unknown. OBJECTIVE: We sought to test the hypothesis that the symptom levels of allergic rhinoconjunctivitis elicited after out-of-season exposure to short ragweed in a PCC and during the natural season for giant ragweed pollen are highly correlated. METHODS: Thirty-one ragweed-sensitive participants recorded symptoms for 15 days during the natural giant ragweed season in San Antonio, Texas. Twenty-six of these participants were challenged to short ragweed pollen in a PCC for 3 hours per day for up to 4 days. RESULTS: In the PCC participants were dichotomized into those in whom low versus high levels of symptoms developed slowly or rapidly (ie, slow/low vs rapid/high). Each successive exposure visit associated with a progressive increase in symptom levels that approximated those experienced during the natural season. Hierarchic clustering identified 3 endotypes: endotypes I and II reflected concordantly low (n= 7) versus high (n = 14) total symptom scores (TSSs) in both the natural season and the PCC, respectively. Accordingly, the correlation between the TSSs recorded in the natural season and in the PCC for these 21 participants was very high. Although participants with endotype III (n = 5) had greater TSSs in the natural season than in the PCC, the degree of correlation between the TSSs remained high. CONCLUSIONS: Our findings affirm our hypothesis, underscore the high cross-reactivity between distinct pollens, and highlight the utility of the PCC to identify novel allergy endotypes that might have contrasting mechanistic underpinnings and potentially therapeutic responses.